EU Assesses Regulatory Needs for Fluorinated Aliphatic Hydrocarbons

Dr Steven Brennan
Dr Steven Brennan
3 min readAI-drafted, expert reviewed
Semiconductor manufacturing

The European Chemicals Agency (ECHA) has completed an assessment of regulatory needs for fluorinated aliphatic hydrocarbons, a group of 28 substances used in manufacturing, electronics, and industrial cleaning. Published on 7 February 2025, the review found potential hazards related to carcinogenicity, reproductive toxicity, endocrine disruption, and environmental persistence. However, no immediate EU-wide regulatory risk management measures are proposed.

Key Insights

The substances remain regulated under the F-Gas Regulation (EU) 2024/573 and the Ozone-Depleting Substances Regulation (EC) No 1005/2009. Industry stakeholders are advised to track potential policy developments that may impact supply chains and compliance obligations.

Substances and Their Industrial Applications

Key Fluorinated Aliphatic Hydrocarbons Under Review

Fluorinated aliphatic hydrocarbons are primarily used in:

  • Fluoropolymer production
  • Semiconductor manufacturing
  • Industrial cleaning agents
  • Heat transfer and lubricant fluids

Substances such as difluoromethane (CAS: 75-10-5) and 1,1-difluoroethane (CAS: 75-37-6) have high industrial relevance, particularly in refrigerants and propellants. The study examined both saturated and unsaturated halofluorocarbons, noting their structural similarities to PFAS without classifying them as such.

Regulatory Landscape and Future Considerations

Current Compliance Requirements

ECHA’s assessment confirms that 14 substances are classified as ozone-depleting under the Montreal Protocol, meaning they are subject to phased-out production and use restrictions. Other substances fall under REACH and CLP regulations, requiring businesses to ensure proper labelling, handling, and reporting.

Potential Future Regulations

Although no immediate regulatory risk management (RRM) actions are proposed, the report indicates that:

  • Changes in reported industrial uses or exposure risks could prompt regulatory reconsiderations.
  • Existing hazard classifications, particularly those related to endocrine disruption and persistence, may trigger new restrictions in the future.

Access the original source

Foresight continuously tracks 1000s of sources and maps updates to your portfolio:

  • Get alerted when changes affect your products or operations
  • Access source documents with full citations
  • Collaborate with your team on alerts and decisions

Related Articles

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly and get the latest insights on regulatory changes affecting chemical compliance.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX